Literature DB >> 19074074

The regulation of hepcidin and its effects on systemic and cellular iron metabolism.

Mark D Fleming1.   

Abstract

Systemic iron homeostasis depends on the regulated expression of hepcidin, a peptide hormone that negatively regulates iron egress from intestinal cells and macrophages by altering the expression of the cellular iron exporter ferroportin. In doing so, hepcidin can control both the total body iron by modulating intestinal iron absorption as well as promote iron available for erythropoiesis by affecting the efficiency with which macrophages recycle iron from effete red blood cells. This review focuses on the systemic and cellular physiology of hepcidin regulation in relation to iron stores, erythropoiesis, inflammation, and hypoxia and how hepcidin regulation and dysregulation contributes to normal iron homeostasis and iron metabolism disorders.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19074074     DOI: 10.1182/asheducation-2008.1.151

Source DB:  PubMed          Journal:  Hematology Am Soc Hematol Educ Program        ISSN: 1520-4383


  35 in total

1.  A tincture of hepcidin cures all: the potential for hepcidin therapeutics.

Authors:  Thomas B Bartnikas; Mark D Fleming
Journal:  J Clin Invest       Date:  2010-11-22       Impact factor: 14.808

2.  A model of erythropoiesis in adults with sufficient iron availability.

Authors:  Doris H Fuertinger; Franz Kappel; Stephan Thijssen; Nathan W Levin; Peter Kotanko
Journal:  J Math Biol       Date:  2012-04-18       Impact factor: 2.259

Review 3.  Murine mutants in the study of systemic iron metabolism and its disorders: an update on recent advances.

Authors:  Thomas B Bartnikas; Mark D Fleming; Paul J Schmidt
Journal:  Biochim Biophys Acta       Date:  2012-01-28

4.  What regulates the iron regulator?

Authors:  Friedrich C Luft
Journal:  J Mol Med (Berl)       Date:  2009-05       Impact factor: 4.599

5.  The type I BMP receptor Alk3 is required for the induction of hepatic hepcidin gene expression by interleukin-6.

Authors:  Claire Mayeur; Lisa K Lohmeyer; Patricio Leyton; Sonya M Kao; Alexandra E Pappas; Starsha A Kolodziej; Ester Spagnolli; Binglan Yu; Rita L Galdos; Paul B Yu; Randall T Peterson; Donald B Bloch; Kenneth D Bloch; Andrea U Steinbicker
Journal:  Blood       Date:  2014-02-05       Impact factor: 22.113

6.  Heme controls ferroportin1 (FPN1) transcription involving Bach1, Nrf2 and a MARE/ARE sequence motif at position -7007 of the FPN1 promoter.

Authors:  Samuele Marro; Deborah Chiabrando; Erika Messana; Jens Stolte; Emilia Turco; Emanuela Tolosano; Martina U Muckenthaler
Journal:  Haematologica       Date:  2010-02-23       Impact factor: 9.941

7.  Increased DMT1 and FPN1 expression with enhanced iron absorption in ulcerative colitis human colon.

Authors:  Emily A Minor; Justin T Kupec; Andrew J Nickerson; Karthikeyan Narayanan; Vazhaikkurichi M Rajendran
Journal:  Am J Physiol Cell Physiol       Date:  2019-11-13       Impact factor: 4.249

8.  A novel rat model of hereditary hemochromatosis due to a mutation in transferrin receptor 2.

Authors:  Thomas B Bartnikas; Sheryl J Wildt; Amy E Wineinger; Klaus Schmitz-Abe; Kyriacos Markianos; Dale M Cooper; Mark D Fleming
Journal:  Comp Med       Date:  2013-04       Impact factor: 0.982

9.  Decreased serum prohepcidin concentration in patients with polycythemia vera.

Authors:  Justyna Kwapisz; Ewa Zekanowska; Joanna Jasiniewska
Journal:  J Zhejiang Univ Sci B       Date:  2009-11       Impact factor: 3.066

10.  Non-HFE hemochromatosis.

Authors:  Paulo Caleb Júnior de Lima Santos; Carla Luana Dinardo; Rodolfo Delfini Cançado; Isolmar Tadeu Schettert; José Eduardo Krieger; Alexandre Costa Pereira
Journal:  Rev Bras Hematol Hemoter       Date:  2012
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.